Showing 321 - 340 results of 2,100 for search '"The Netherlands"', query time: 0.06s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325

    mHealth Intervention for Dementia Prevention through lifestyle Optimisation (MIND-PRO) in a primary care setting: protocol for a randomised controlled trial in people with low SES... by Edo Richard, Esther Van den Berg, Ron Handels, Henrike Galenkamp, Eric P Moll van Charante, Marieke P Hoevenaar-blom, Anne Roos van der Endt, Martien J H Kas

    Published 2025-02-01
    “…Secondary outcomes include the Cardiovascular Risk Factors, Ageing and Dementia risk score and its individual risk factors, and disability, physical activity, depressive symptoms, cognitive functioning and daily distance moved.Ethics and dissemination The MIND-PRO trial is funded by the Netherlands Organisation for Health Research and Development (ZonMw, grant number 10510032120004) and approved by the Ethics Committee of Amsterdam UMC (reference: METC 2023.0770). …”
    Get full text
    Article
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330
  11. 331
  12. 332
  13. 333

    Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure by Philippine Kiès, Marieke Nederend, Ralph M.L. Neijenhuis, Anna E. van Groningen, Monique R.M. Jongbloed, Hubert W. Vliegen, J. Wouter Jukema, Anastasia D. Egorova

    Published 2025-01-01
    “…This study aimed to evaluate the medium-term QOL changes in sRV failure patients treated with sacubitril/valsartan.Methods In this single-centre, prospective cohort study, patients with symptomatic sRV failure completed the Netherlands Organisation for Applied Scientific Research/Academic Hospital Leiden Questionnaire for Adult’s Health-Related Quality of Life (TAAQOL) at baseline and after starting treatment with sacubitril/valsartan. …”
    Get full text
    Article
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340